|
| ||||
|
SECURITIES AND EXCHANGE COMMISSION | ||||
|
FORM 8-K | ||||
|
Current Report Pursuant | ||||
|
Date of Report (Date of Earliest Event Reported) |
March 30, 2007 | |||
|
Bioenvision, Inc. | ||||
|
(Exact Name of Registrant as Specified in its Charter) | ||||
|
Delaware | ||||
|
(State or Other Jurisdiction of Incorporation) | ||||
|
001-31787 |
|
13-4025857 | ||
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) | ||
|
345 Park Avenue, 41st Floor, New York, New York |
10154 | |||
|
(Address of Principal Executive Offices) |
(Zip Code) | |||
|
(212) 750-6700 | ||||
|
(Registrant’s Telephone Number, Including Area Code) | ||||
|
Not Applicable | ||||
|
(Former Name or Former Address, if Changed Since Last Report) | ||||
|
| ||||
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2): | ||||
|
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
|
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
|
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
|
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||
|
|
|
|
|
Item 9.01 |
Financial Statements and Exhibits. |
|
|
(d) Exhibits |
| |
|
|
Exhibit Number |
Description | |
|
|
23.1 |
Consent of J.H. Cohn LLP, Independent Registered Public Accounting Firm | |
|
|
23.2 |
Consent of Deloitte & Touche LLP, Prior Independent Registered Public | |
|
|
23.3 |
Consent of Grant Thornton LLP, Prior Independent Registered Public | |
|
|
1 |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BIOENVISION, INC.
|
March 30, 2007 |
By: |
/s/ David P. Luci |
|
|
Name: |
David P. Luci |
|
|
Title: |
Executive Vice President, General Counsel and Corporate Secretary |
|
|
2 |
|
EXHIBIT INDEX
|
23.1 |
Consent of J.H. Cohn LLP, Independent Registered Public Accounting Firm |
|
23.2 |
Consent of Deloitte & Touche LLP, Prior Independent Registered Public |
|
23.3 |
Consent of Grant Thornton LLP, Prior Independent Registered Public |
|
|
1 |
|